Literature DB >> 2209723

Immunocytochemical identification of the human alpha 2-macroglobulin receptor in monocytes and fibroblasts: monoclonal antibodies define the receptor as a monocyte differentiation antigen.

S K Moestrup1, K Kaltoft, C M Petersen, S Pedersen, J Gliemann, E I Christensen.   

Abstract

The alpha 2-macroglobulin receptor was recently purified from rat liver and human placenta. Three different monoclonal antibodies have now been raised against the human receptor and expression of the 440-kDa receptor protein is demonstrated in human placenta, fibroblasts, liver, and monocytes by immunoblot analysis. Flow cytometric studies showed that anti-alpha 2-macroglobulin receptor monoclonal antibodies bind to 90-100% of the blood monocyte population and not to other blood cells. This defines the alpha 2-macroglobulin receptor as a monocyte differentiation antigen, different from any of the classified leucocyte cluster determinants. Electron microscopic gold immunocytochemistry revealed the subcellular distribution of the receptor in human cultured monocytes and fibroblasts. In these cells, 18-33% of the gold particles were found on the outside of the plasma membrane, and in fibroblasts, especially, in coated invaginations. The intracellular receptors were mainly distributed in vesicles and tubular structures.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2209723     DOI: 10.1016/0014-4827(90)90185-d

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.

Authors:  R P Czekay; T A Kuemmel; R A Orlando; M G Farquhar
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

2.  Interaction of human peripheral blood monocytes with apoptotic polymorphonuclear cells.

Authors:  Tomasz P Mikołajczyk; Joanna E Skrzeczyńska-Moncznik; Mirosław A Zarebski; Ewa A Marewicz; Anna M Wiśniewska; Magdalena Dzieba; Jerzy W Dobrucki; Juliusz R Pryjma
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

3.  Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions.

Authors:  J Luoma; T Hiltunen; T Särkioja; S K Moestrup; J Gliemann; T Kodama; T Nikkari; S Ylä-Herttuala
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

4.  Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and the 39-kd receptor-associated protein in human trophoblasts.

Authors:  G Coukos; M E Gåfvels; S Wisel; E A Ruelaz; D K Strickland; J F Strauss; C Coutifaris
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

5.  Urokinase-type plasminogen activator receptor is internalized by different mechanisms in polarized and nonpolarized Madin-Darby canine kidney epithelial cells.

Authors:  F Vilhardt; M Nielsen; K Sandvig; B van Deurs
Journal:  Mol Biol Cell       Date:  1999-01       Impact factor: 4.138

6.  Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation.

Authors:  M Rudling; M Gåfvels; P Parini; G Gahrton; B Angelin
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

7.  39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.

Authors:  I Warshawsky; G Bu; A L Schwartz
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

8.  Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues.

Authors:  S K Moestrup; J Gliemann; G Pallesen
Journal:  Cell Tissue Res       Date:  1992-09       Impact factor: 5.249

Review 9.  Alpha-2-Macroglobulin in Inflammation, Immunity and Infections.

Authors:  Jennifer Vandooren; Yoshifumi Itoh
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.